On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Cancer Hospital of Chinese Academy of Medical Sciences

InstitutionResearch output, impact & collaborations

Cancer Hospital of Chinese Academy of Medical Sciences is a institution indexed in ScholarIQ from OpenAlex.

What is known about Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQrecord summary

Cancer Hospital of Chinese Academy of Medical Sciences is a research organisation in Beijing, CN. OpenAlex records 3,326 works and 135,757 citations for it. 1,225 researchers list it as their most recent affiliation.

How many works does Cancer Hospital of Chinese Academy of Medical Sciences have?

ScholarIQindexed works

Cancer Hospital of Chinese Academy of Medical Sciences has 3,326 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Cancer Hospital of Chinese Academy of Medical Sciences →

How many citations does Cancer Hospital of Chinese Academy of Medical Sciences have?

ScholarIQcitation count

Cancer Hospital of Chinese Academy of Medical Sciences has 135,757 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Cancer Hospital of Chinese Academy of Medical Sciences →

How many researchers are at Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQresearcher count

Cancer Hospital of Chinese Academy of Medical Sciences has 1,225 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQavg h-index

Cancer Hospital of Chinese Academy of Medical Sciences has an average h-index of 32 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQror

The ROR for Cancer Hospital of Chinese Academy of Medical Sciences is on the source record.

Open the ROR →

What is the OpenAlex record for Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQopenalex

The OpenAlex for Cancer Hospital of Chinese Academy of Medical Sciences is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQtop researchers by citations

Wenxian Wang · Lung Cancer Treatments and Mutations

234 works3,268 citations

What are the most-cited papers on Cancer Hospital of Chinese Academy of Medical Sciences?

ScholarIQmost cited works

Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Kai Zhang, Xiaohua Hong, Zhengbo Song, Yu Xu, Chengcheng Li, Guoqiang Wang, Yuzi Zhang, Xiaochen Zhao, Zhengyi Zhao, Jing Zhao, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Shangli Cai, Feifei Gu, Yue Hu, Chunwei Xu, Wenxian Wang, Zhenkun Lou, Yong Zhang, Li Liu

Clinical Cancer Research. 2020138 Citations

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

Zhijie Wang, Jianchun Duan, Guoqiang Wang, Jing Zhao, Jiachen Xu, Jiefei Han, Zhengyi Zhao, Jun Zhao, Bo Zhu, Minglei Zhuo, Jianguo Sun, Hua Bai, Rui Wan, Xin Wang, Kailun Fei, Shuhang Wang, Xiaochen Zhao, Yuzi Zhang, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Yuezong Bai, Hua Dong, Lei Xiong, Yanhua Tian, Di Wang, Chunwei Xu, Wenxian Wang, Junling Li, Xingsheng Hu, Shangli Cai, Jie Wang

Journal of Thoracic Oncology. 201994 CitationsOPEN ACCESS

A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR‐TKI resistance

Wenxian Wang, Zhengbo Song, Yiping Zhang

Cancer Medicine. 201691 CitationsOPEN ACCESS

TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma

Wenjing Xiao, Nan Du, Taoyuan Huang, Jinan Guo, Xingkui Mo, Tao Yuan, Yong Chen, Ting Ye, C. Xu, Wenxian Wang, Guoqiang Wang, Shangli Cai, Jing Chen

EBioMedicine. 201884 CitationsOPEN ACCESS

Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study

Wenxian Wang, C. Xu, Huafei Chen, Jinhao Jia, Liping Wang, Huijing Feng, Hong Wang, Zhengbo Song, Nong Yang, Yongchang Zhang

Lung Cancer. 202173 Citations

How much of the research on Cancer Hospital of Chinese Academy of Medical Sciences is open access?

ScholarIQopen access share

80%OPEN ACCESS

Gold

40%

Green

20%

Hybrid

Bronze

20%

Closed

20%